BR

Britema Rabha

Active Director Director DIN 10798410
DIN 10798410 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Britema Rabha

Data last updated:

Britema Rabha is a Director at Hnsm Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10798410
Primary Designation Director
Industry Paper
First Appointment 09 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hnsm Pharmaceuticals Private Limited U21001AS2024PTC025921
Director09 Oct 20242024Active

Board colleagues of Britema Rabha

NameDINCompanyDesignation
Soneswari Rabha10494251Hnsm Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hnsm Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Britema Rabha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Britema Rabha

Britema Rabha currently holds 1 directorship: Hnsm Pharmaceuticals Private Limited (Director, since 09 Oct 2024).

Britema Rabha was first appointed on 09 Oct 2024 as Director at Hnsm Pharmaceuticals Private Limited.

The current boards of Britema Rabha's companies include Soneswari Rabha (Hnsm Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available